Free Trial
→ BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (From Goldco Precious Metals) (Ad)tc pixel Free TAK Stock Alerts

Takeda Pharmaceutical (TAK) SEC Filings & 10K Form

Takeda Pharmaceutical logo
$14.98 +0.02 (+0.10%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$14.98 0.00 (0.00%)
As of 08/29/2025 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Takeda Pharmaceutical SEC Filings

Export to Excel
DateFilerForm TypeView
08/20/2025
8:02 PM		Takeda Pharmaceutical (Filer)
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
08/07/2025
7:51 PM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
07/31/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2025
5:02 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2025
5:05 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
5:45 AM		Takeda Pharmaceutical (Subject)
Wozniewski Thomas Otto Claus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:29 AM		Ricci Gabriele (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:32 AM		Platford Giles Richard (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:34 AM		Kim Julie So-Young (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:36 AM		Duprey Lauren Rusckowski (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:38 AM		Pignagnoli Agosti Marcello (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:41 AM		Sequeira Ramona (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:43 AM		Bitetti Teresa Marie (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
5:17 AM		Amakawa Akiko (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:20 AM		Plump Andrew Stewart (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:23 AM		Takeda Pharmaceutical (Subject)
Weber Christophe Pierre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:26 AM		Shannon Elaine Mary (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/08/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2025
9:33 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
5:06 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2025
7:26 PM		Takeda Pharmaceutical (Subject)
Form FWP
06/26/2025
8:55 PM		Takeda Pharmaceutical (Filer)
Takeda U.S. Financing Inc. (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
06/26/2025
5:21 AM		Takeda Pharmaceutical (Filer)
Takeda U.S. Financing Inc. (Filer)
Form 424B5
06/25/2025
6:31 AM		Takeda Pharmaceutical (Filer)
Takeda U.S. Financing Inc. (Filer)
Form F-3ASR
06/25/2025
5:23 AM		Takeda Pharmaceutical (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
06/25/2025
5:02 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2025
5:04 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2025
5:08 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2025
5:08 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
5:06 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:27 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:12 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:14 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:20 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
5:24 AM		Takeda Pharmaceutical (Filer)
Form SD
Specialized Disclosure Report  
05/12/2025
5:19 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)

Right now, we’re witnessing a monumental shift in the world.tc pixel

Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia.
05/08/2025
5:14 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2025
5:19 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2025
5:08 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2025
5:12 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2025
5:07 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
5:00 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:46 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2025
5:40 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
5:28 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
5:33 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
5:06 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2025
5:13 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/12/2025
7:06 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
01/30/2025
5:24 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:25 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:28 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:29 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:23 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
5:07 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
5:00 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:28 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:19 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:21 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:TAK) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsoredtc pixel